Fat loss
Cagrilintide
- 5mg*10vials USD 113.00
- 10mg*10vials USD 219.00
Reference price. The concierge confirms the amount before payment.
4.6 / 5 · 933 reviewsAfter the order is submitted, quote the order number when you write to the concierge.
Features
Long-acting satiety-inducing peptides; highly effective when used in combination with GLP-1.
Overview
Cagrilintide is a long-acting, acylated amylin analogue—a pancreatic hormone—designed for once-weekly subcutaneous injection. It activates central amylin receptors, promoting satiety, slowing gastric emptying, and reducing food intake. In Phase 2 and Phase 3 clinical trials, cagrilintide induced dose-dependent weight loss, with side effects primarily being gastrointestinal in nature.
Precautions
Reconstitution: Add 3.0 mL of bacteriostatic water → concentration ~1.67 mg/mL
Typical weekly dosage range: 0.6–4.5 mg once weekly (titrated gradually over 4–6 weeks)
Simple measurement: 1 unit = 0.01 mL ≈ 0.0167 mg (16.7 micrograms)
How to use
1. Draw 3.0 mL of bacteriostatic water using a sterile syringe.
2. Inject slowly along the inner wall of the vial; avoid creating foam or vigorous agitation.
3. Gently swirl or roll the vial until the contents are completely dissolved (do not shake).
4. Label with the date and concentration; store refrigerated at 2–8°C, protected from light.
5. Use within 30 days of reconstitution; discard if the solution appears cloudy or contains particulate matter.
Storage
Lyophilized: Store at -20°C in a dry, dark place; minimize exposure to moisture.
After reconstitution: Store refrigerated at 2–8°C; use within 30 days, and avoid freeze-thaw cycles.
Reviews
4.6 / 5
933 reviews
Showing the latest 100 reviews.
-
★★★★★
VXC•••••••E7D3
Australia
2026-10-26 18:42
The box was plain and undamaged. The vial matched the description. No issues on arrival.
-
★★★★★
VXC•••••••5C82
Japan
2026-10-26 14:49
The handoff at the depot was slow. The inner pack was clean. I am satisfied with the item.
-
★★★★★
VX6•••••••C666
Singapore
2026-10-26 10:56
Arrival was calm and on schedule. The contents were undamaged. Pleased with how it was sent.
-
★★★★★
VXA•••••••A540
Hong Kong
2026-10-26 07:04
Tracking was a day late. The vial was fine. The product side was fine.
-
★★★★★
VX9•••••••CE5C
France
2026-10-26 03:11
It arrived a couple of days after the first date. The description matched. The listing did not overstate it.
-
★★★★★
VXD•••••••EA61
United Kingdom
2026-10-25 23:18
The box arrived in good shape. The page description was accurate. Everything checked out.
-
★★★★★
VX0•••••••3B92
Hong Kong
2026-10-25 19:26
It arrived a couple of days after the first date. The batch note was readable. The delay was minor.
-
★★★★★
VX4•••••••4423
Germany
2026-10-25 15:33
The outer carton was solid. The vial matched the description. Everything checked out.
-
★★★★★
VX1•••••••8C1E
Germany
2026-10-25 11:40
The box arrived in good shape. The label matches the listing. Clear from start to finish.
-
★★★★★
VX8•••••••FBC5
Canada
2026-10-25 07:47
The carton was dry and closed. The vial matched the description. Clear from start to finish.
Buyer review
Enter the order number and the phone number from checkout. Both must match an order that includes this product.
Also listed
Fat loss
CJC-1295+IPA(CP10)
This formulation combines CJC-1295 (without DAC)—a modified growth hormone-releasing hormone (GHRH) analog—with Ipamorelin, a selective growth hormone secretagogue (GHS). CJC-1295 (without DAC) produces a sustained, dose-dependent increase in GH and IGF-1 levels, while Ipamorelin selectively stimulates GH release without increasing ACTH or cortisol.
Reference priceUSD 116.00
Fat loss
Retatrutide
Retatrutide is an investigational triple-receptor agonist peptide (targeting GLP-1, GIP, and glucagon receptors) currently under development for the treatment of obesity and type 2 diabetes. Phase II clinical trials have demonstrated significant weight loss, with patients in the high-dose group achieving a weight reduction of up to 24% over 48 weeks. This educational program outlines a once-weekly subcutaneous administration regimen, incorporating a gradual dose-escalation approach to minimize gastrointestinal side effects.
Reference priceUSD 45.00
Fat loss
Tirzepatide
Tirzepatide is a dual incretin receptor agonist composed of 39 amino acids. It activates both GLP-1 and GIP receptors, thereby enhancing glucose-dependent insulin secretion, suppressing glucagon, delaying gastric emptying, and reducing appetite. With a half-life of approximately 5 days, it is convenient to administer via a once-weekly subcutaneous injection. Clinical trials have demonstrated that tirzepatide offers superior efficacy in terms of glycemic control and weight loss compared to selective GLP-1 receptor agonists.
Reference priceUSD 40.00
Fat loss
Tesamorelin
Tesamorelin is a synthetic 44-amino acid peptide analog that resembles growth hormone-releasing hormone (GHRH). It stimulates the release of endogenous growth hormone and increases IGF-1 levels, thereby promoting lipolysis and providing metabolic benefits. Tesamorelin has been approved by the FDA for the reduction of visceral adipose tissue in individuals with HIV-associated lipodystrophy.
Reference priceUSD 41.00